Bio-Rad Laboratories, Inc. (BIO) Q1 2026 Earnings Call Transcript
Bio-Rad Laboratories, Inc. held its Q1 2026 earnings call on April 30, 2026, discussing financial results and business performance. Company executives, including President Jonathan DiVincenzo and CFO Roop Lakkaraju, provided updates on operations and strategy. Analysts from firms such as Nephron Research, Wells Fargo, Jefferies, Citigroup, and Exchange Research participated in the Q&A session.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4897318-bio-rad-laboratories-inc-bio-q1-2026-earnings-call-transcript"},"author":{"@type":"Person","name":"SA Transcripts","url":"https://seekingalpha.com/author/sa-transcripts"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New York","addressRegion":"NY","postalCode":"10001","addressCountry":"US"},"alternateName":["SeekingAlpha","SA"],"brand":[{"@type":"Brand","name":"Seeking Alpha Premium","url":"https://seekingalpha.com/subscriptions/premium"},{"@type":"Brand","name":"Seeking Alpha…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
